Maravai Lifesciences Holdings Inc (MRVI) — Cash Flow Reinvestment Rate
Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow Reinvestment Rate of 1.41x as of September 2024, reinvesting $18.55 Million (capex $9.59 Million plus investments $-8.96 Million) from operating cash flow of $13.14 Million. Explore MRVI capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Maravai Lifesciences Holdings Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Maravai Lifesciences Holdings Inc across 6 annual periods. Also explore total assets of Maravai Lifesciences Holdings Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Maravai Lifesciences Holdings Inc (2019–2024)
Year-by-year capital reinvestment analysis for Maravai Lifesciences Holdings Inc. For live market cap and broader valuation context, see MRVI market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.23x | $53.97 Million | $7.46 Million | $29.66 Million | ▲ +371.7% |
| 2023 | 1.53x | $193.48 Million | $126.22 Million | $65.55 Million | ▲ +188.6% |
| 2022 | 0.53x | $284.70 Million | $535.98 Million | $17.09 Million | ▲ +62.5% |
| 2021 | 0.33x | $120.50 Million | $368.57 Million | $14.85 Million | ▲ +58.1% |
| 2020 | 0.21x | $31.48 Million | $152.19 Million | $25.41 Million | ▼ -85.5% |
| 2019 | 1.42x | $34.30 Million | $24.11 Million | $17.15 Million | — |